Listen in as these topics are discussed:

• The EBM approach is becoming necessary giving rising costs, and clinicians must be equipped with the right information to talk about evidence with insurers, colleagues, and their patients.

• We also make the point in our introduction and conclusion that it is the responsibility of insurers, clinicians, and patients to become informed about the evidence for and against various interventions, not just those they are already familiar with.

• The special focus issue of The Spine Journal that Dr. Scott Haldeman and Dr. Dagenais edited is probably one of the easiest sources that clinicians can use to access the evidence on various interventions they commonly use for chronic LBP.

• It’s written by clinicians and for clinicians, trying as much as possible to avoid heavy epidemiologic jargon and provide practical recommendations where possible.

• People can think of the focus issue as what would happen if they could speak directly to top clinicians and researchers and ask them to explain and justify their use of a particular therapy.